• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Contrast media reactions rarely happen, study finds

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 31 No 12
Volume 31
Issue 12

Concerns about the potential adverse reactions of patients to iodinated and gadolinium-based contrast agents used with CT and MRI may be more perceived than real, according to Mayo Clinic researchers.

Concerns about the potential adverse reactions of patients to iodinated and gadolinium-based contrast agents used with CT and MRI may be more perceived than real, according to Mayo Clinic researchers.

Dr. Christopher H. Hunt and colleagues in Rochester, MN, reviewed 456,930 episodes of contrast media administration. From this base, 522 cases of mostly mild adverse effects were identified. Reactions included nausea, vomiting, and skin rashes. Only 16 cases, 10 severe reactions to low-osmolar iodinated agents and six to gadolinium, needed transfer to an emergency department for further observation and treatment. One patient died, but possibly due to unrelated causes. Pretreatment with corticosteroids helped bring down the incidence of adverse effects (AJR 2009;193[4]:1124-1127). Adverse contrast reactions can occur, but they are rarely severe and most require only observation and supportive care, Hunt said.

Recent Videos
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.